Literature DB >> 23669389

Dose responses of proveblue methylene blue in an experimental murine cerebral malaria model.

Jérome Dormoi, Bruno Pradines.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23669389      PMCID： PMC3719760          DOI： 10.1128/AAC.00634-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.

Authors:  Sophie H Adjalley; Geoffrey L Johnston; Tao Li; Richard T Eastman; Eric H Ekland; Abraham G Eappen; Adam Richman; B Kim Lee Sim; Marcus C S Lee; Stephen L Hoffman; David A Fidock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

2.  Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin.

Authors:  Jérôme Dormoi; Aurélie Pascual; Sébastien Briolant; Rémy Amalvict; Serge Charras; Eric Baret; Emilie Huyghues des Etages; Michel Feraud; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

3.  In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.

Authors:  Aurélie Pascual; Maud Henry; Sébastien Briolant; Serge Charras; Eric Baret; Rémy Amalvict; Emilie Huyghues des Etages; Michel Feraud; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

4.  Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.

Authors:  Jérome Dormoi; Sébastien Briolant; Camille Desgrouas; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

5.  Artemisone effective against murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Nicholas Hunt; Annael Bentura-Marciano; James A McQuillan; Ho-Wai Chan; Wing-Chi Chan; Yechezkel Barenholz; Richard K Haynes; Jacob Golenser
Journal:  Malar J       Date:  2010-08-09       Impact factor: 2.979

6.  Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.

Authors:  Jean-Baptiste Souraud; Sébastien Briolant; Jérome Dormoi; Joel Mosnier; Hélène Savini; Eric Baret; Rémy Amalvict; Raoulin Soulard; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2012-01-10       Impact factor: 2.979

7.  Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.

Authors:  Joël Lelièvre; Maria Jesus Almela; Sonia Lozano; Celia Miguel; Virginia Franco; Didier Leroy; Esperanza Herreros
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.

Authors:  Peter E Meissner; Germain Mandi; Boubacar Coulibaly; Steffen Witte; Théophile Tapsoba; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; R Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Journal:  Malar J       Date:  2006-10-08       Impact factor: 2.979

9.  Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.

Authors:  Jérome Dormoi; Sébastien Briolant; Camille Desgrouas; Bruno Pradines
Journal:  Malar J       Date:  2013-04-15       Impact factor: 2.979

10.  Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.

Authors:  Boubacar Coulibaly; Augustin Zoungrana; Frank P Mockenhaupt; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter E Meissner; Olaf Müller
Journal:  PLoS One       Date:  2009-05-05       Impact factor: 3.240
View more
  9 in total

1.  Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.

Authors:  Bécaye Fall; Cheikhou Camara; Mansour Fall; Aminata Nakoulima; Pierre Dionne; Bakary Diatta; Yaya Diemé; Boubacar Wade; Bruno Pradines
Journal:  Malar J       Date:  2015-02-06       Impact factor: 2.979

2.  Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria.

Authors:  Colin Ohrt; Qigui Li; Nicanor Obaldia; Rawiwan Im-Erbsin; Lisa Xie; Jonathan Berman
Journal:  Malar J       Date:  2014-10-21       Impact factor: 2.979

3.  Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data.

Authors:  Lionel Almeras; Leonardo K Basco; Cheikh Sokhna; Stéphane Ranque; Philippe Parola; Christian Devaux; Philippe Brouqui; Michel Drancourt; Bruno Pradines
Journal:  New Microbes New Infect       Date:  2018-07-04

4.  Inhibitory action of phenothiazinium dyes against Neospora caninum.

Authors:  Luiz Miguel Pereira; Caroline Martins Mota; Luciana Baroni; Cássia Mariana Bronzon da Costa; Jade Cabestre Venancio Brochi; Mark Wainwright; Tiago Wilson Patriarca Mineo; Gilberto Úbida Leite Braga; Ana Patrícia Yatsuda
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

5.  Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum.

Authors:  Mathieu Gendrot; Océane Delandre; Marie Gladys Robert; Francis Tsombeng Foguim; Nicolas Benoit; Rémy Amalvict; Isabelle Fonta; Joel Mosnier; Marylin Madamet; Bruno Pradines; On Behalf Of The French National Reference Centre For Imported Malaria Study Group
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-09

6.  The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.

Authors:  Katharina Ehrhardt; Christiane Deregnaucourt; Alice-Anne Goetz; Tzvetomira Tzanova; Valentina Gallo; Paolo Arese; Bruno Pradines; Sophie H Adjalley; Denyse Bagrel; Stephanie Blandin; Michael Lanzer; Elisabeth Davioud-Charvet
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

7.  Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.

Authors:  Henriette Bosson-Vanga; Jean-François Franetich; Valérie Soulard; Daniel Sossau; Maurel Tefit; Bocar Kane; Jean-Christophe Vaillant; Steffen Borrmann; Olaf Müller; Nathalie Dereuddre-Bosquet; Roger Le Grand; Olivier Silvie; Dominique Mazier
Journal:  Malar J       Date:  2018-04-03       Impact factor: 2.979

8.  Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia.

Authors:  Richard E Kast
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

9.  Methylene blue inhibits replication of SARS-CoV-2 in vitro.

Authors:  Mathieu Gendrot; Julien Andreani; Isabelle Duflot; Manon Boxberger; Marion Le Bideau; Joel Mosnier; Priscilla Jardot; Isabelle Fonta; Clara Rolland; Hervé Bogreau; Sébastien Hutter; Bernard La Scola; Bruno Pradines
Journal:  Int J Antimicrob Agents       Date:  2020-10-16       Impact factor: 15.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.